Today: 7 February 2026
Subscribe

Student Loan Forgiveness Is Back – 2 Million Borrowers Get Relief as Trump Overhauls Repayment

Student Loan Forgiveness Is Back – 2 Million Borrowers Get Relief as Trump Overhauls Repayment

Forgiveness Finally Arrives for Long-Term Borrowers After months of suspense, thousands of Americans are now seeing decades-old student loans wiped clean. The Education Department’s quiet move to resume IBR loan forgiveness in the first week of October has been met with relief – and tears of joy – from borrowers who’ve made 20 or 25 years of payments. Many received what the community calls the “golden email,” with the message: “You are now eligible to have some or all of your federal student loan(s) discharged because you have reached the necessary number of payments under your Income-Based Repayment Plan.” btimesonline.com
9 October 2025
Meme Coin Frenzy & Mega-Raises: Inside October 2025’s ICO and Token Sale Boom

Meme Coin Frenzy & Mega-Raises: Inside October 2025’s ICO and Token Sale Boom

In the detailed report below, we break down October 2025’s most notable ICOs and token sales – from project purposes and funding stats to expert insights – and examine what these offerings signal about the crypto market’s direction. Uptober Market Fuels a Token Sale Revival October 2025 earned the nickname “Uptober” as crypto markets rallied to levels unseen since 2021’s peak. Bitcoinblasted to a record high above $125,000 on October 5ts2.tech, roughly 4× higher than a year prior, and Ether hovered near $4,500 (just below its all-time high)ts2.tech. Major altcoins surged in tandem: Binance’s BNB token hit ~$1,190 – a new peak – after a 39% monthly
9 October 2025
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

What Is the FTSE 100 Index? The FTSE 100 (Financial Times Stock Exchange 100) is the flagship stock index of the London Stock Exchange, tracking the 100 largest companies by market capitalization listed in the UK. Often called the “Footsie,” it serves as a barometer of British large-cap equities. The index is market-cap weighted, meaning each company’s influence on the index is proportional to its market value (adjusted for free-float shares)theguardian.com. In practical terms, bigger companies like Shell or HSBC move the FTSE 100 far more than smaller constituents. The FTSE 100 is maintained by FTSE Russell (part of London Stock Exchange Group) and is
9 October 2025
·
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deal: Inside the 2025 Rally, Financials & Rivalry

 AMD’s headquarters sign in Silicon Valley. The company’s stock has surged amid blockbuster AI deals and strong chip demand in 2025. Stock Performance & Recent Rally Advanced Micro Devices (AMD) has been one of 2025’s top semiconductor stocks, staging a dramatic rally after a volatile 2024. As of early October, AMD shares traded around $230+ – nearly double their level at the start of the yearfinviz.com. The stock had already climbed ~30% year-to-date by late Septemberts2.techts2.tech, outperforming both the S&P 500 and the Philly Semiconductor Index. Then came an explosive surge in October: AMD’s stock leapt about 29% in a matter of days, topping $213 by Oct.
8 October 2025
···
Duolingo Stock Surges on AI Buzz – Latest Price, Bold Forecasts & Big Risks in 2025

Duolingo Stock Surges on AI Buzz – Latest Price, Bold Forecasts & Big Risks in 2025

Stock Price & Recent Performance Duolingo’s stock has experienced whiplash in 2025. After a strong first half, DUOL tumbled nearly 50% from summer highs, erasing most of its prior 12-month gainsmarketbeat.com. Over the past three months the stock slid 35%, dramatically underperforming both the edtech industry (+26%) and the S&P 500 (+11%) in that spannasdaq.com. This “nasty slide” sent shares down toward the $280s by late Septembermarketbeat.com. Investors grew skittish over post-pandemic user trends and fears that emerging AI tools could steal Duolingo’s thundermarketbeat.com. October brought a turnaround. This week, DUOL bounced off recent lows, surging roughly 5–6% on Oct 8 aloneainvest.com. Shares climbed from about
8 October 2025
··
Amazon’s Finance Teams Unleash AI for Complex Tasks – Transforming Corporate Finance

Amazon Stock Surges on New AI Push – Latest Price, Key News & 2025 Outlook

Stock Price & Recent Performance (October 2025) As of October 8, 2025, Amazon’s stock trades around $225 per sharestockanalysis.com. It has risen modestly in early October, bouncing from about $219 at the start of the month to the mid-$220s rangestockanalysis.com. This week’s ~1.5% uptick follows a period of volatility in late September. Year-to-date, AMZN is roughly flat to slightly up (low single-digit percentage gains), lagging the broader S&P 500 and most other “Magnificent Seven” tech giants. Notably, Amazon hit an all-time high near $242 in early February 2025, but a summer tech sell-off and profit-taking pulled the stock down about 10% from that peakts2.tech. Chart-wise,
8 October 2025
···
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Company Overview and Mission Tempus AI, Inc. is an American health technology company founded in 2015 by entrepreneur Eric Lefkofsky (best known as co-founder of Groupon). Headquartered in Chicago, Tempus was born from Lefkofsky’s personal mission to improve cancer care after his wife’s battle with breast canceren.wikipedia.org. The company’s core focus is on applying AI and data analytics to personalized medicine. Tempus has built what it calls an “operating system” for healthcare: a platform that ingests vast amounts of clinical and molecular data (gene sequences, lab tests, medical records, imaging, etc.) and makes it accessible for treatment decisions and researchinsidermonkey.com. Its goal is to enable doctors and
8 October 2025
···
Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

Rare Interstellar Comet 3I/ATLAS – a 10-Billion-Year-Old Time Capsule – Flies Past Mars

A Visitor from Beyond the Solar System Humanity has waited a long time to study a comet from another star – and suddenly, within a decade, we’ve had three. 3I/ATLAS (officially 3I/2025 A1) is the latest of these rare interstellar interlopers. It was first detected moving through the outer Solar System in June 2025 with an exceptionally eccentric orbit. Follow-up observations quickly confirmed what its speed and trajectory implied: this object was not bound to the Sun’s gravityts2.tech. By July 2025, the Minor Planet Center designated it the third interstellar object ever foundts2.tech. Like its predecessors – the cigar-shaped 1I/‘Oumuamua and cometary 2I/Borisov – 3I/ATLAS is
8 October 2025
·
Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Google’s Pixel 10 Pro Fold Shakes Up the Smartphone Wars with AI Tricks, Durability & Bold Design

Pixel 10 Pro Fold: Google’s AI-Powered Foldable Flagship Google’s new Pixel 10 Pro Fold is the star of its 2025 lineup – a device that blends cutting-edge hardware with Google’s latest AI software. This foldable phone is branded as the “Pro Fold” variant of the Pixel 10 family, emphasizing that it shares the same core specs and AI features as the Pixel 10 Pro slab phonests2.tech. When closed, it looks like a typical premium smartphone with a 6.4″ OLED display; opened up, it reveals a spacious 8″ tablet-like screen – slightly larger than its predecessor and rival Galaxy foldsts2.tech. The design retains
8 October 2025
···
Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Xenetic Biosciences (XBIO) Stock Skyrockets – Is the Biotech’s 2025 Rally for Real?

Stock Performance: The 2025 Rollercoaster Ride Xenetic’s stock was relatively quiet for most of 2025 until early October, when it suddenly erupted. By Oct 8, 2025, XBIO had skyrocketed to levels not seen in years. On that day alone, the stock soared 123% to $9.58 (from a prior $4.29 close)finanzen.ch, after touching intraday highs well above $10. This move extended a remarkable run from under $3.50 at the start of the week to nearly $12-13 intraday on Oct 8ainvest.com. In fact, at one point XBIO was up about +195% in a single session according to real-time trackerstimothysykes.com. Such gains are extraordinary – even by penny stock standards
8 October 2025
·
Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Plant-Based Food Stock Goes Crypto: Above Food (ABVE) Skyrockets in 2025

Above Food Ingredients Inc. is a Canadian plant-based food tech company that went public via SPAC merger in 2024 Stocktwits. In 2025, its stock ABVE has been on a wild ride – climbing from penny-stock levels to over $4, an almost 8-fold increase in under a year Marketbeat. This meteoric rise comes as Above Food pivots beyond organic grains into gold-backed cryptocurrencies and next-gen financial tech, capturing investor imagination. Below, we dive into Above Food’s mission, business model, financials, stock performance, forecasts, expert commentary, strategic moves, ESG profile, and the latest news driving this micro-cap’s buzz. Company Background and Mission Founded in Regina, Saskatchewan, in 2023, Above Food began with a
8 October 2025
··
Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Cipher Mining (CIFR) Stock Skyrockets on AI Pivot & Bitcoin Boom – Next Crypto Powerhouse?

Company Overview: Operations & Business Model Cipher Mining Inc. is a pure-play Bitcoin miner operating industrial-scale data centers with a focus on ultra-low-cost powerts2.tech. The company strategically locates its facilities in regions with cheap, renewable-rich electricity (e.g. West Texas), often building behind-the-meter or adjacent to wind and solar farmsts2.techts2.tech. Its flagship “Black Pearl” site near Odessa, TX is a 150 MW facility designed for both Bitcoin mining and high-performance computing (HPC) workloadsts2.tech. As of mid-2025, Cipher’s deployed hashrate reached about 16.8 EH/s (exahashes per second), using next-gen ASIC machines for high energy efficiencyts2.tech. The company had aggressively expanded capacity – a 2.6 GW development pipeline of power projects positions Cipher for further growthts2.tech.
8 October 2025
··
Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Adaptimmune Therapeutics (ADAP) Stock Skyrockets 42% – Is This Biotech Turnaround for Real?

Therapy (Target) Indication Status (2025) Current Ownership TECELRA(afamitresgene, targets MAGE-A4) Synovial sarcoma (unresectable/metastatic) FDA approved Aug 2024 Biospace; ~16 patients treated in launch year Nasdaq. Sold to US WorldMeds (2025) Adaptimmune Letetresgene (lete-cel, NY-ESO-1) MRCLS and synovial sarcoma (advanced solid tumors) Phase II completed (42% response rate) Stocktitan; FDA Breakthroughdesignation in 2025 Stocktitan; BLA filing planned for 2025. Sold to US WorldMeds (2025) Adaptimmune Uzatresegene (uza-cel, next-gen TCR) Solid tumors (MAGE-A4 TCR, partnered with Galapagos) Preclinical/IND-enabling stage; partnership deal $665M signed 2024 Fiercebiotech. Sold to US WorldMeds (2025) Adaptimmune PRAME-targeted TCR Multiple cancers (PRAME antigen) Preclinical (IND-enabling on hold to cut costs) Biospace. Retained by Adaptimmune Adaptimmune CD70-targeted TCR Hematologic malignancies
8 October 2025
·
Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Snowflake Stock Soars on AI Boom – Inside SNOW’s 2025 Rally and What’s Next

Below, we dive deeper into each of these areas – from Snowflake’s business model and financials to the latest news, analyst insights, competitive dynamics, and what to expect going forward. Company Overview and Business Model Snowflake Inc. is a cloud data platform provider, offering data warehousing as a service alongside a suite of data analytics and sharing capabilities. Unlike traditional databases tied to a single cloud or on-premises, Snowflake’s platform is cloud-agnostic – it runs across Amazon AWS, Microsoft Azure, and Google Cloud, allowing customers to unify their data in one system regardless of cloud providermarkets.chroniclejournal.com. This flexibility has been a major selling point
8 October 2025
··
CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

CrowdStrike Stock Skyrockets Amid Cybersecurity Boom – Is the Rally Justified? (2025 Update)

Sources: Official company reports and press releases; Yahoo Finance and Zacks Investment Research; Reuters and CNBC interviews; TS2 Tech stock analysis and cybersecurity newsts2.technasdaq.commarkets.financialcontent.commarketbeat.comts2.techsiliconangle.comts2.tech. These provide the latest financial data, expert commentary, and industry context as of October 8, 2025.
8 October 2025
··
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Detailed Report 1. Stock Performance and Valuation Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025 (the last trading day before the U.S. Columbus Day holiday), the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior sessionstockinvest.us. Technical analysts at Stockinvest.us noted the shares were near the upper part of a wide falling trend and predicted a possible trading range of $26.40–$28.73 on Oct 8, with longer‑term support around $26 and resistance near $31stockinvest.us. While short‑term signals were positive, they cautioned that the overall downward trend remainsstockinvest.us. Because multiple financial
8 October 2025
··
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Why Intellia Therapeutics’ Stock Could Be a Gene‑Editing Goldmine in 2025 – Deep Dive into NTLA’s Prospects

Quick Facts (as of 8 Oct 2025) Recent Performance and News Phase 1 data fuels rally Intellia’s October rally was triggered by longer‑term Phase 1 results for nexiguran ziclumeran (nex‑z), an in‑vivo CRISPR therapy for transthyretin (ATTR) amyloidosis. A GlobeNewswire release (Sept 25 2025) reported that a single dose produced a rapid, deep and durable reduction of serum TTR levels—mean reduction 92 % at 24 months and 90 % at 36 monthsglobenewswire.com. Patients also showed clinical improvements or stabilization of neuropathy and cardiac markersglobenewswire.com, and safety findings were mostly mild infusion‑related eventsglobenewswire.com. CEO John Leonard said the data “demonstrate rapid, deep and durable TTR reductions with meaningful clinical improvements” and reiterated
8 October 2025
··
CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

CRISPR Therapeutics Stock Update (Oct 8 2025): Why Gene‑Editing Bulls See Big Upside

Stock Price, Volume and Sentiment According to AAII, CRSP’s share price on 8 Oct 2025 closed at $77.727, up 10.06 % from the previous close. The stock traded between $70.77 and $78.38 that day and has risen ~20 % during October. Over the prior year the share price ranged from $30.04 to $73.95, and year‑to‑date performance stood at +97.5 %. Trading volume on INDmoney’s quote was 3.1 million sharesindmoney.com. Fintel’s data as of 7 Oct 2025 list a market cap of roughly $6.2 billion, a beta of 1.32 and a short interest of 26.3 %, suggesting significant volatility and short‑seller interestfintel.io. The average one‑year price target of $81.3 implies modest
8 October 2025
Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia Therapeutics (NTLA) Soars on CRISPR Breakthroughs – Latest Updates & Stock Outlook

Intellia at a Glance: CRISPR Trailblazer in 2025 Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a clinical-stage biotechnology company at the forefront of CRISPRgene editing medicines. Headquartered in Cambridge, MA, Intellia was one of the first companies to harness CRISPR-Cas9 technology to develop potential in vivo therapies – treatments delivered directly into the body to edit genes inside patients’ cells. In fact, Intellia reported the first-ever clinical evidence that CRISPR could provide a therapeutic benefit in humans via in-body gene editing, showing in 2021 that a one-time IV infusion could drastically lower a disease-causing protein in patients ts2.tech. This pioneering achievement, accomplished with their transthyretin amyloidosis (ATTR)
8 October 2025
··
TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

TSMC Stock Soars on AI Boom: Record Highs, Big Ambitions & Geopolitical Risks (Oct 2025 Update)

Overview: TSMC’s Business and Recent Performance Taiwan Semiconductor Manufacturing Co. (TSMC) is the world’s largest contract chipmaker (pure-play foundry), producing advanced semiconductors for clients like Apple, NVIDIA, AMD, and many otherstaiwannews.com.twts2.tech. Rather than selling its own branded chips, TSMC builds chips to order, focusing on cutting-edge manufacturing processes. This model has made TSMC a pillar of global tech supply chains and given it an estimated 60%+ market share of the overall foundry market (and over 90% share in the most advanced nodes)ts2.tech. Financially, TSMC has been on a strong growth trajectory. In Q2 2025, TSMC’s revenue reached US$30.1 billion, a 44%year-on-year surge, with net profit of T$398.3 billion, driven by
8 October 2025
··
1 … 1,474 1,475 1,476 1,477 1,478 … 1,636

Stock Market Today

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

SAP stock price: Treasury stake tops 5% as buyback focus builds into next week

7 February 2026
SAP SE closed at 171.22 euros on Xetra Friday, up 0.43%, after disclosing its treasury shares rose above 5% of capital, reaching 61,737,035 shares. The increase follows the launch of a buyback plan worth up to 2.6 billion euros through July 2026. SAP’s U.S. shares finished at $203.34. Investors await SAP’s Integrated Report on Feb. 26 and next results on April 23.
Go toTop